Largest Diagnostics & Research Companies by Market Cap
The Diagnostics & Research sector has 167 publicly listed stocks with a combined market cap of $892.92 Billion. iSpecimen Inc leads the sector with a market cap of $3.86 Million. This ranking covers all Diagnostics & Research stocks globally — from large-cap industry leaders to mid-cap and small-cap companies — ranked by market capitalization and updated daily.
Total Market Cap (USD)
$892.92 Billion
Companies Listed
167
Largest Company
iSpecimen Inc
| Rank | Company | Market Cap (USD) | Market Cap (Local) | Country | Price | 24h Change | 7d Change | 24h Volume |
|---|---|---|---|---|---|---|---|---|
| 151 |
iSpecimen Inc
NASDAQ:ISPC |
$3.86 Million | $3.86 Million | USA | $5.62 | +7.46% | +3364.86% | 1.25 Billion |
| 152 |
Genetic Technologies Ltd
NASDAQ:GENE |
$3.71 Million | $3.71 Million | USA | $1903.20 | +0.23% | -0.77% | 19.44K |
| 153 |
Telo Genomics Corp
V:TELO |
$3.63 Million | CA$5.02 Million | Canada | CA$0.05 | +0.00% | -9.09% | 836.89K |
| 154 |
StageZero Life Sciences Ltd
TO:SZLS |
$3.58 Million | CA$4.94 Million | Canada | CA$0.04 | +0.00% | +0.00% | 0.00 |
| 155 |
Centogene N.V.
NASDAQ:CNTGF |
$3.07 Million | $3.07 Million | USA | $0.12 | +0.00% | -0.33% | 136.37K |
| 156 |
ALPHAHELIX MOL.DIAGN. SK1
F:4MB |
$1.47 Million | €1.26 Million | Germany | €0.02 | +0.00% | -6.67% | 8.00K |
| 157 |
LUNGLIFE AI INC. DL-0001
F:9H4 |
$1.06 Million | €904.73K | Germany | €0.03 | +0.00% | -6.76% | 17.00K |
| 158 |
Wellfully Ltd
AU:WFL |
$1.05 Million | AU$1.48 Million | Australia | AU$0.00 | +0.00% | +0.00% | 0.00 |
| 159 |
ProPhase Labs Inc
NASDAQ:PRPH |
$378.96K | $378.96K | USA | $0.14 | +3.29% | +12.69% | 2.32 Million |
| 160 |
Abingdon Health Plc
LSE:ABDX |
$259.67K | GBX2.13 Billion | UK | GBX8.50 | +0.00% | -10.53% | 6.15 Million |
| 161 |
genedrive plc
LSE:GDR |
$119.01K | GBX978.12 Million | UK | GBX0.95 | +2.70% | +2.70% | 121.94 Million |
| 162 |
Oxford Biodynamics PLC
LSE:OBD |
$107.03K | GBX879.64 Million | UK | GBX0.21 | +0.00% | -10.87% | 265.72 Million |
| 163 |
ANGLE plc
LSE:AGL |
$94.18K | GBX774.07 Million | UK | GBX2.40 | -9.43% | +29.73% | 84.65 Million |
| 164 |
Verici Dx Plc
LSE:VRCI |
$88.39K | GBX726.43 Million | UK | GBX0.48 | +1.05% | -8.57% | 35.74 Million |
| 165 |
Proteome Sciences PLC
LSE:PRM |
$71.69K | GBX589.22 Million | UK | GBX1.68 | +12.00% | +30.23% | 7.90 Million |
| 166 |
LungLife AI Inc
LSE:LLAI |
$15.48K | GBX127.23 Million | UK | GBX4.15 | -2.35% | +22.06% | 7.36 Million |
| 167 |
Biocept Inc.
NASDAQ:BIOCQ |
$262.00 | $262.00 | USA | $0.00 | +0.00% | +0.00% | 14.32K |
Track real-time market capitalization of largest public companies in the Diagnostics & Research industry. Compare marketcap, analyze stock performance, and discover leading diagnostics & research corporations. View all industries